Health Technology Assessment Coordination Group & Cooperation with European Medicines Agency (#EMA). The public consultation on the new implenting act on the cooperation of the two bodies has been completed. The new #HTAR takes into consideration the assessment of #medicines, #medicaldevices and #invitrodiagnostics. All comments performed by european regulators, patient grous, consultansies etc are available in the link below. In a few months the new regulation will be voted and clarify all issues commented. The exchange of information of the two bodies involves the following: i) planning and forecast of the Joint Clinical Assessment (JCA) & Joint Scientific Consultations (JSC). ii) identifications of patients, clinical experts and other relevant experts to be involved in the procedure iii) general scientific and technical matters for #JCA & #JSC iv) security of sharing and protection of confidential information exchanged between #EMA, HTA secretariat and coordination group. Will keep you posted on the progress of the #HTAR and the relevant info. https://lnkd.in/d8g9qy7U
Pharmecons Easy Access Ltd
Hospitals and Health Care
York, England 185 followers
Pharmecons Easy Access is an international health technology assessment consultancy,specializing in market access issues
About us
Pharmecons Easy Access is an international health technology assessment agency, specializing in market access issues, health economics and patient preferences studies. We are based in York UK and Athens Greece. Pharmecons Team has extensive experience in health economic modeling, social sciences, reimbursement dossiers preparation and patient satisfaction studies. We are experts in writing reports for reimbursement authorities, building value dossiers for the broader healthcare community and communication plan with specific key messages from patients, medical community and health care professionals. Through the use of our multi-disciplinary expertise and cutting edge methodology, including modelling, patient preferences. cost-effectiveness and budget impact analyses, we seek to provide individualized solutions to pharmaceutical industry to best support products' added value. Our vision is to provide expert guidance with tailor-made solutions, through every phase of product development, to leverage products' value proposition, enabling Easy Access to our customers' products (pharmaceuticals or technologies). Pharmecons cooperates with the university of York and have a great network of international researchers based in UK and Greece.
- Website
-
http://www.pharmecons.com
External link for Pharmecons Easy Access Ltd
- Industry
- Hospitals and Health Care
- Company size
- 2-10 employees
- Headquarters
- York, England
- Type
- Privately Held
- Founded
- 2017
- Specialties
- health economics, market access, budget impact, cost effectiveness, patient reported outcomes, value dossiers, reimbursement dossiers, Patient Engagement Studies, PASS Studies, DRGs, and Health Policy
Locations
-
Primary
63-65 Heworth Road
York, England YO31 0AA, GB
Employees at Pharmecons Easy Access Ltd
Updates
-
On the occasion of Pharmecons Easy Access Ltd participation in a European program proposal related to the prevention of cancer under HORIZON-MISS-2024-CANCER-01-03 as an HTA and IVDR/MDR expert, we quote a very useful classification guide for IVDR products, which has been formulated by the BSI company entitled IVDR Assessment tools. A snapshot of the IVD Classification is presented at the picture below and at the link you can find the complete guide. https://lnkd.in/d5akavai
-
Greek Patient Association will be Supervised by the Ministry of Health. New Era in Patient Engagement studies in Greece!
Very promising news for the Greek Patient Association. The Greek Ministry of Health will put the GR association under its supervision with the objective to involve them in the decision making process and upgrade patient engagement studies. Will keep you posted on the ministerial decision.
Αναβαθμίζεται θεσμικά η Ένωση Ασθενών Ελλάδος - healthdaily.gr | Health Daily
https://healthdaily.gr
-
We are proud that the CEO of Pharmecons Easy Access Ltd has contributed in the publication of Springer Nature Group book entitled "Intelligent Technologies for Healthcare Business Applications". The specific book chapter is involved with the Evaluation of Key Performance Indicators and the Measures which should be used during the study design of a #clinicaltrial of a #medical or #digital technology.
The end of summer vacation coincides with the publication of a book chapter that I have written entitled "The Evaluation of Key Performance Indicators for Medical and Digital Technologies in Healthcare" published by Springer Nature Group Switzerland. The titled of the e-book which is also available with hard cover is "Intelligent Technologies for Healthcare Business Applications". The book is avaialble below and remain at your disposal for any question or information you may need. #Keyperformanceindicators, #digitaltechnologies, #economicevaluation #KPIs
Intelligent Technologies for Healthcare Business Applications
link.springer.com
-
The cost consequences analysis of HosmartAI EU technologies has been completed! Please click on the link below to read the final newsletter of the technologies and the economic analysis of each technology. If you want to perform an economic evaluation of medical or digital technologies we are here to assist you! https://lnkd.in/dkmkyzsw #hosmartai #economicevaluation #digitaltechnologies #medicaltechnologies #costconsequencestechnologies
-
Participation of Pharmecons CEO at SFEE SUMMIT and Important Update on RWE & Medical Devices
SFEE SUMMIT INSIGHTS ON GREEK PATIENT ACCESS AND RWE At the 18th of June, I had the opportunity to participate in the #SFEESUMMIT. It was a very interesting and informative event, full of vivid discussions and good networking opportunities. It was great to re-connect with ex-colleagues from the #pharmaceuticalindustry, clients and last but certainly not least, the great collaborators from Croma, my loving Athina Moissidou and Venia Allamani, and from JUST ONE | Recruitment & Executive Search agency, Matthieu Gardaire who elevated the #headhunding search in new levels with transparency, respect and openness, resulting in enormous growth in the pharmaceutical industry as well! Great to see you all in good health and try to cope with all challenges of the Greek healthcare environment and pharmaceutical market. It was very nice to see all involved stakeholders #government, #industry, #academia, #patient groups, #scientific associations, #consulting firms, #ECexecutives #medicaldevices technologies to participate in active discussions and align in the common objective, #innovativetreatments in timely manner for Greek patients. From policy making perspective it was great to see alignment and common understanding among the #pharmaindustry and #govenment in the challenges of the GR HC sector, ie. Increase public expenditure in pharmaceuticals, reduce clawback rates (which are interconnected fields anyway), reward innovation and enhance patient Greek access in innovative medicines in timely manner within the average of EZ countries, keep existing patent levels duration at 8 years, without any reduction. The important aspect from health economics & policy perspective is that the ministry of health & ministry of digital governance will eventually permit the secondary use of #RWE. This was the first time we heard that from the mouth of GR officials. The second important element, was the growing interest in #digital and #medical devices and the numerous organizations that have been created along this #ecosystem which were unknown, at least to me. The insightful presentation of Aristos Doxiadis was really interesting and enabled the link of different parts of the puzzle which were missing. The holistic pathway of the #cancerpatient was discussed with a fantastic panel of stakeholders covering holistically the topic. Let's hope that in the near future will be able to see the outcomes from the 1st Greek #oncologyregistry from ΕΟΠΕ - HeSMO Overall impression positive, many promises which need to be realized in the near future to allow #patientaccess to Greek patients and #RWE data access to Greek scientists and decision makers. #SFEESUMMIT #DIGITALTECHNOLOGIES #RWE #EHDS #PATIENTACCESS
-
🏥The SMART Hospital with AI Technologies Made in Greece On Friday, May 31st, the AUTH Medical Physics & Digital Innovation Lab, and Signal Processing & Biomedical Technology Unit - AUTH in collaboration with Netcompany-Intrasoft and Pharmecons Easy Access Ltd presented in AHEPA University Hospital the results of the GR AI ultrasound technologies which developed for HosmartAI EU project in the areas of #cardiology, #obstetrics and #gastrenterology. The CEO of Pharmecons Easy Access Ltd Dr. Magda Hatzikou presented the Economic Evaluation of the Medical AI Ultrasound Technologies and the necessary next steps to be followed in order for the new devices to acquire commercial value. The highlight from #HEOR perspective, is that the cost of development is counterbalanced by the high effectiveness, leading to cost-effective and cost-saving technologies. A big 🙏 to all scientists who completed successfully this great challenge and managed to design such added value technologies. A big 🙏 to European Commission for giving the #scientificcommunity and #SMEs the opportunity to participate in such value added project with extraordinary results.💫 🚀 Greater things are yet to come. #HosmartAI #DigitalHealth #Economicevaluation #HEOR
-
Completion of public consultation on the #HealthTechnologyAssessmentRegulation (HTAR) by European Commission. Active participation by #patientorganizations from all #EUcountries.
Completion of public consultation on the #HealthTechnologyAssessmentRegulation (HTAR). Yesterday the public consultation of HTAR was completed. It is very encouraging to read the constuctive feedback by 129 European and global #federations, #scientificorganizations, #universities, #pharmaceuticalindustry and most importantly 42% from #patientassociations. The active engagement of patient associations in the HTA procedure is amazing and designates the willingness of patients to participate actively in the procedure. I would like to thank all patient representatives from all EU countries for the support in the new HTAR. Most comments performed by Belgium, Germany, France, Netherlands and Spain. Greece participated as well, with the statements of ΣΦΕΕ / SFEE - Σύνδεσμος Φαρμακευτικών Επιχειρήσεων Ελλάδος, #Hellenicleagueagainstrheumatism/ELEANA, University of Ioannina. The comments and the statistics can be found below. https://lnkd.in/gTNqrssp
-
The last plenary meeting of HosmartAI EU was performed at the incredible premises of San Camillo IRCCS at Lido di Venezia. Pharmecons Easy Access Ltd contributed to the economic evaluation and Key Performance Indicators Identification of the Medical & Digital AI technologies. A new journey begins this time for our CEO Magda Hatzikou as a reviewer of Innovative Health Initiative Projects! Thank you HosmartAI EU and European Commission for this great opportunity.
The last plenary meeting has come to an end. ✨ Thank you to all partners that have participated with valuable inputs and for the contribution to reach the positive results! 🏆 A special thanks to San Camillo IRCCS for the excellent hospitality! #innovation #healthcare #ai #research
-
The CEO of Pharmecons Easy Access Magda Hatzikou was certified in Health Informatics. Another proof of Pharmecons Easy Access dedication to the continuous support in patient access to digital and medical technologies! https://lnkd.in/dJz-xqPJ
🎖️The certification process of Medical Informatics by EFMI-European Federation for Medical Informatics during the HosmartAI #Horizon2020FundedProgram has been completed successfully! Medical Informatics certification is part of our dedication in the evaluation of performance & economic evaluation of medical and digital technologies to enable patient access and full reimbursement in such added value technologies!